| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 600364000 | Blood gas | 65 |
| 20080269583 | Detection and Monitoring of Stress Events During Sleep - A computer-implemented method for monitoring a patient ( | 10-30-2008 |
| 20080300475 | Laryngoscope with Time Indicating Means and Method for Use Thereof - The present invention discloses a laryngoscope ( | 12-04-2008 |
| 20080306367 | Detection of Body Sounds - Disclosed is a method for detecting and monitoring body sounds in humans and animals, in which bioacoustic sensors and analyzers that are mounted downstream are used for the stationary or mobile long-term monitoring of intensive care patients' respiration, for example. The patients' lung sounds are detected and stored along with measured data which are available right away especially for the early detection of diseases and acute disturbances. Adequately monitoring intestinal sounds makes it possible to evaluate peristalsis and detect mechanical/paralytic ileus early on. An early warning system for the clinical sector immediately generates signals allowing doctors and nurses to take rapid action in case of an emergency. The inventive apparatus requires a maximum of only three bioacoustic sensors ( | 12-11-2008 |
| 20090131775 | Carbon dioxide and activity monitoring - An implanted heart monitor includes sensors that measure various aspects of the heart failure patient's heart. A remote heart monitoring system connects the implanted heart monitor to a care provider, such as a physician. The data provided by the implanted heart monitor permits the care provider to obtain valuable data on the heart in order to make health care decisions affecting the heart failure patient's treatment. In many cases, the measurement of core body temperature and other patient data will enable the care provider to alter the patient's treatment to address the patient's condition. The implanted heart monitor can communicate over a wireless communication link with an external monitor. The implanted heart monitor may be implemented as part of a pacing device (i.e., pace maker) or may be a separate unit devoted to monitoring functions. The external monitor communicates with a monitoring station over a communication link. The monitoring station can operate as a centralized data collection unit, collecting data from multiple external monitors and multiple implanted heart monitors. Various other aspects of a heart failure patient's heart and/or body can be monitored, such as heart rate, blood pH levels, blood CO | 05-21-2009 |
| 20090156921 | CARDIAC ABLATION CATHETER WITH OXYGEN SATURATION SENSOR - Positioning of the distal end of a catheter at a desired location, for example, in the desired atrium of a patient's heart, can be determined or verified through measurement of blood gas values proximate to the distal end. In one embodiment, an oximeter is used to monitor oxygen saturation, for example, to distinguish between de-oxygenated venous blood and well-oxygenated arterial blood. Optical signals may be transmitted to the distal end of the catheter and received therefrom via optical fibers. Specifically, a catheter ( | 06-18-2009 |
| 20090156922 | BLOOD MONITORING SYSTEM - The present invention is directed towards apparatuses and methods for the automated measurement of blood analytes and blood parameters for bedside monitoring of patient blood chemistry. Particularly, the current invention discloses a programmable system that can automatically draw blood samples at a suitable programmable time frequency (or at predetermined timing), can automatically analyze the drawn blood samples and immediately measure and display blood parameters such as glucose levels, hematocrit levels, hemoglobin blood oxygen saturation, blood gases, lactate or any other blood parameter. | 06-18-2009 |
| 20090182216 | MOISTURE CONTROL IN A TRANSDERMAL BLOOD ALCOHOL MONITOR - Moisture may build up inside an alcohol monitor that is securely attached to a human subject due to the inlet air from the subject's skin surface which constantly emits water vapor in the form of insensible skin perspiration. As the warm moist air which has very high humidity flows along the air flow path through decreasing temperatures within the alcohol monitor, moisture will be removed from the air through condensation. The condensation problem is solved by lowering the humidity level in the air sample by mixing the very humid air sample from the body with less humid ambient air, which increases the dew point for condensation. Increasing the dew point in the air sample means that there must be a greater change in temperature along the air flow path of the air sample in order to cause the moisture in the air sample to condense and become water. | 07-16-2009 |
| 20090209839 | Methods And Systems For Alerting Practitioners To Physiological Conditions - Embodiments of the present disclosure provide systems and methods for monitoring a patient to produce a signal representing a blood oxygen concentration. The signal may be analyzed to determine the presence of one or more sleep apnea events, and an integral of the signal may be calculated if the signal is outside of a set range or threshold. A practitioner may choose to be informed of the presence of sleep apnea events if the blood oxygen concentration is less then a preset limit, if an upper limit has been reached for an integral representing the severity of the oxygen deprivation over time, or anytime sleep apnea events may be present in the signal | 08-20-2009 |
| 20100113908 | System And Method For Facilitating Observation Of Monitored Physiologic Data - Present embodiments are directed to a system and method capable of detecting and graphically indicating physiologic patterns in patient data. For example, present embodiments may include a monitoring system that includes a monitor capable of receiving input relating to patient physiological parameters and storing historical data related to the parameters. Additionally, the monitoring system may include a screen capable of displaying the historical data corresponding to the patient physiological parameters. Further, the monitoring system may include a pattern detection feature capable of analyzing the historical data to detect a physiologic pattern in a segment of the historical data and capable of initiating a graphical indication of the segment on the screen when the physiologic pattern is present in the segment. | 05-06-2010 |
| 20100113909 | System And Method For Facilitating Observation Of Monitored Physiologic Data - Present embodiments are directed to a system and method capable of detecting and graphically indicating physiologic patterns in patient data. For example, present embodiments may include a monitoring system that includes a monitor capable of receiving input relating to patient physiological parameters and storing historical data related to the parameters. Additionally, the monitoring system may include a screen capable of displaying the historical data corresponding to the patient physiological parameters. Further, the monitoring system may include a pattern detection feature capable of analyzing the historical data to detect a physiologic pattern in a segment of the historical data and capable of initiating a graphical indication of the segment on the screen when the physiologic pattern is present in the segment. | 05-06-2010 |
| 20100152563 | DUAL FLOW BLOOD MONITORING SYSTEM - A dual blood flow monitoring system includes an electronic first sensor, an electronic second sensor, and an electronic monitoring device in communication with the first sensor and the second sensor. The first sensor monitors a first blood flow and the second sensor monitors a second blood flow. The electronic monitoring device is operative to receive signals from the sensors and to calculate and display a differential value representing a difference between the at least one parameter of the first blood flow and the at least one parameter of the second blood flow. A dual blood flow monitoring system is provided in a method for simultaneously monitoring extracorporeal arterial and venous blood flows, in which the sensors are placed in communication with respective tubing lines carrying the arterial and venous blood flows. | 06-17-2010 |
| 20100249559 | Medical Device For Assessing Intravascular Blood Volume And Technique For Using The Same - Embodiments of the present invention relate to a system and method for determining a physiologic parameter of a patient. Specifically, embodiments of the present invention include methods and systems for correcting a pulse oximetry plethysmographic waveform variability measurement based on parameters that may influence the waveform variability. The corrected measurement may be used to estimate intravascular blood volume and/or fluid responsiveness of a patient. | 09-30-2010 |
| 20100249560 | OXYGEN SENSOR - The present invention generally relates to systems and methods for determining oxygen in a sample, or in a subject. In one aspect, the present invention is generally directed to an article exhibiting a determinable feature responsive to oxygen, such as oxygen-sensitive particles. The particles may exhibit a determinable change with a change in oxygen concentration, and such particles can accordingly be used to determine oxygen. For example, in one set of embodiments, the particles may be at least partially coated with a protein, such as hemoglobin, that is able to interact with oxygen. In some cases, the protein may aggregate under certain conditions (e.g., under relatively low oxygen concentrations), and such protein aggregation may be used, for example, to cause the particles to become aggregated, which can be determined in some way. In some cases, such aggregation may be irreversible; i.e., the degree of aggregation corresponds to the most extreme oxygen concentrations that the proteins were exposed to. Such articles may be used, for example, to determine oxygen within a sample, or within a subject, such as a human subject. For instance, the article may be formed as a skin patch, or administered to the skin of a subject, e.g., on the surface of the skin, within the dermis or epidermis, etc., to determine oxygen within the subject. | 09-30-2010 |
| 20100292556 | METHODS AND SYSTEMS FOR MANAGING, CONTROLLING AND MONITORING MEDICAL DEVICES VIA ONE OR MORE SOFTWARE APPLICATIONS FUNCTIONING IN A SECURE ENVIRONMENT - Systems and methods that include configurations of a medical device, user device and service platform are described. Embodiments may include a secure network to run medical applications that control and/or monitor the medical device. An online store may be provided for storing and distributing medical applications to the user device and medical device. A secure environment may be provided within the user device and medical device that protects the integrity of medical applications running on those devices. A service platform may provide a service that enables a medical authority to certify and monitor the medical applications. In some implementations, various third parties and the user of the user device may be allowed to manage and monitor the medical device. | 11-18-2010 |
| 20100298683 | PHYSIOLOGICAL MONITORING DEVICES AND METHODS - Devices and methods are described for wirelessly monitoring an emergency responder. In some embodiments, a sensor acquires values of carboxyhemoglobin in blood. The values are recorded and are used to provide feedback to a user. The feedback includes at least one of visible, tactile, and audible information. | 11-25-2010 |
| 20100324397 | Methods and Apparatuses for Navigating the Subaracnhnoid Space - Disclosed is a method of navigating a spinal subarchnoid space in a living being, that includes percutaneously introducing a device into the spinal subarachnoid space at an entry location. The device has a first passageway that is sized to slidably receive, and work with, at least a guidewire. The device can be a catheter or a sheath. The method can also include advancing the device within the spinal subarachnoid space at least more than 10 centimeters from the entry location. Alternatively, the method can include advancing the device within the spinal subarachnoid space to facilitate intracranial access with a second device introduced through the first passageway. Also disclosed is a device suited for attachment to a patient's skin, such as a sheath, that includes an elongated member, a skin-attachment apparatus having a flexible skin-attachment flap, and a valve apparatus. | 12-23-2010 |
| 20100331649 | INTERACTIVE ANALYSIS METHOD FOR BIOSIGNALS - An interactive analysis method for biosignals is disclosed. The method includes steps of providing at least a biosignal acquisition device, a user utilizing the biosignal acquisition device to acquire at least one kind of biosignals therefrom, the user uploading the acquired biosignals to a service platform through a network, wherein the service platform provides at least a set of processing means for said kind of biosignals with at least an algorithm included therein, the user selecting at least a desired processing means from the set of processing means, the service platform performing the selected processing means on the uploaded biosignals for producing an analysis result, the user deciding a handling flow for the analysis result, the user deciding a handling flow for the uploaded biosignals, and the service platform performing the handling flows decided by the user. Therefore, through the biosignal interactive analysis method, not only the users can customize their own operation procedure, but the physiological examination and diagnosis also can be performed at any desired time and location once the biosignal acquisition device is connected to the service platform via network. | 12-30-2010 |
| 20110021897 | Heart Failure Monitor Quicklook Summary for Patient Management Systems - Continuous remote monitoring of patients based on data obtained from an implantable hemodynamic monitor provides an interactive patient management system. Using network systems, patients are remotely monitored to continuously diagnose and treat heart-failure conditions. A screen displayable summary provides continuous feedback and information to physicians, patients and authorized third parties. The quick look summary includes various sites and presentation tailored to match the patients' and physicians' needs. The quick look summary further includes intelligent features that understand and retain the user's interests, preferences and use patterns. Patients, physicians and other caregivers are seamlessly connected to monitor and serve the chronic needs of heart-failure patients in a reliable and economic manner. | 01-27-2011 |
| 20110054283 | METHODS AND DRESSING SYSTEMS FOR PROMOTING HEALING OF INJURED TISSUE - A dressing system is disclosed which has a sponge and a near infrared spectroscopy sensor positioned adjacent to the sponge for monitoring oxygenation levels of tissue adjacent to the sponge. The dressing system may further include a tube coupled to the sponge for removing fluid from the sponge. The dressing system comprises: a sponge; and a tensioning system coupled to the sponge. The tensioning system further comprises a central longitudinal member coupled to the sponge; and at least one tensioning member coupled to the central longitudinal member. A sequential compression system comprises: an envelope sleeve dressing; and a bladder that is both expandable and retractable. A tissue filler system is also described and includes a plurality of tubes; wherein each of the plurality of tubes further comprises apertures; and a pump coupled to at least one of the tubes which obviates the need for any sponge or wound screen. | 03-03-2011 |
| 20110060204 | Negative Pressure Dressing and Method of Using Same - Disclosed herein are apparatuses and methods for treating a wound by applying reduced or negative pressure to the wound. The apparatus can include a wound cover ( | 03-10-2011 |
| 20110071378 | Signal Processing Warping Technique - Methods and systems are provided for using time-frequency warping to analyze a physiological signal. One embodiment includes applying a warping operator to the physiological signal based on the energy density of the signal. The warped physiological signal may be analyzed to determine whether non-physiological signal components are present. Further, the same warping operator may be applied to signal quality indicators, and the warped physiological signal may be analyzed based on the warped signal quality indicators. Non-physiological signal components, or types of non-physiological noise sources, may be identified based on a comparison of the physiological signal with the signal quality indicators. Non-physiological signal components may also be identified based on a neural network of known noise functions. In some embodiments, the non-physiological signal components may be removed to increase accuracy in estimating physiological parameters. | 03-24-2011 |
| 20110082357 | METHOD AND APPARATUS FOR CO2 EVALUATION - A method for evaluating CO | 04-07-2011 |
| 20110087084 | FACE MASK TYPE VITAL SIGNS MEASURING APPARATUS AND VITAL SIGNS MANAGEMENT SYSTEM USING THE SAME - There are provided a face mask type vital signs measuring apparatus and a vital signs management system using the same. The face mask type vital signs measuring apparatus according to an exemplary embodiment of the present invention may include: a detector detecting a vital sign; an analyzer analyzing the detected vital sign; a display displaying the analyzed vital sign; a transmitter transmitting the analyzed vital sign; and a face mask with the detector, the analyzer, the display, and the transmitter attached thereto. | 04-14-2011 |
| 20110092787 | ENDOCAPSULE - An endocapsule has a measurement chamber therein containing a sensor that detects at least one metabolic product of a specific bacterium in a hollow organ of a human or animal gastrointestinal tract. The endocapsule is introduced into the hollow organ wherein detection of the at least one metabolic product takes place. | 04-21-2011 |
| 20110098547 | SENSORS HAVING PROTECTIVE ELUTING COATING AND METHOD THEREFOR - An apparatus includes an implantable device, such as a chronically implantable device that has a device body. One or more chemical sensors are coupled with the device body. A drug eluting substance is disposed at a location including at least one of on, directly adjacent, or near the one or more chemical sensors, where the drug eluting substance prevents fibrotic growth on the one or more chemical sensors. | 04-28-2011 |
| 20110124995 | SENSOR HOLDER FOR MEDICAL SENSOR - A sensor holder for a medical sensor. The sensor holder includes a housing surrounding a hollow for a subject appendage, the housing having a first channel for a gas volume following the hollow, a first aperture, a second aperture and a third aperture for a ventilation of the gas volume of the first channel. | 05-26-2011 |
| 20110230742 | TRACHEAL TUBE SENSOR DISPOSED ON PERMEABLE MEMBRANE - Various embodiments of an tracheal tube having a sensor coupled to a selectively permeable membrane are provided. In some embodiments, the membrane may be permeable to one or more blood gases and/or blood analytes. Certain embodiments of the endotracheal tube may be capable of deploying the sensor during intubation to sense one or more indicators of blood flow characteristics, such as a level of blood gases and/or blood analytes, in the respiratory tract. Embodiments of the present invention may include positioning of the sensor in a variety of suitable positions with respect to the permeable membrane, such as mounting the sensor to the underside of an inflatable permeable membrane. | 09-22-2011 |
| 20110288389 | OXYGEN SENSOR - The present invention generally relates to systems and methods for determining oxygen in a sample, or in a subject. In one aspect, the present invention is generally directed to an article exhibiting a determinable feature responsive to oxygen, such as oxygen-sensitive particles. The particles may exhibit a determinable change with a change in oxygen concentration, and such particles can accordingly be used to determine oxygen. For example, in one set of embodiments, the particles may be at least partially coated with a protein, such as hemoglobin, that is able to interact with oxygen. In some cases, the protein may aggregate under certain conditions (e.g., under relatively low oxygen concentrations), and such protein aggregation may be used, for example, to cause the particles to become aggregated, which can be determined in some way. In some cases, such aggregation may be irreversible; i.e., the degree of aggregation corresponds to the most extreme oxygen concentrations that the proteins were exposed to. Such articles may be used, for example, to determine oxygen within a sample, or within a subject, such as a human subject. For instance, the article may be formed as a skin patch, or administered to the skin of a subject, e.g., on the surface of the skin, within the dermis or epidermis, etc., to determine oxygen within the subject. | 11-24-2011 |
| 20110301445 | HEART FAILURE MONITOR QUICKLOOK SUMMARY FOR PATIENT MANAGEMENT SYSTEMS - Continuous remote monitoring of patients based on data obtained from an implantable hemodynamic monitor provides an interactive patient management system. Using network systems, patients are remotely monitored to continuously diagnose and treat heart-failure conditions. A screen displayable summary provides continuous feedback and information to physicians, patients and authorized third parties. The quick look summary includes various sites and presentation tailored to match the patients' and physicians' needs. The quick look summary further includes intelligent features that understand and retain the user's interests, preferences and use patterns. Patients, physicians and other caregivers are seamlessly connected to monitor and serve the chronic needs of heart-failure patients in a reliable and economic manner. | 12-08-2011 |
| 20120059235 | Animal Instrumentation - An approach to instrumentation and telemetry of physiological and physical parameters of an animal and its environment has particular application to horses. This approach improves the effectiveness of one or more of evaluation, diagnosis, care conditioning or monitoring of animals because it does not require use of restrictive equipment such as force plates or treadmills, and it can provide objective and quantitative data that is complete, accurate, precise and reproducible, and this data can be obtained under real-world conditions, for either or both of more or less real-time or continuous processing of data to perform the monitoring or diagnosis. That is, in such an approach objective and quantitative data can be collected under real-world conditions and this data can be processed and the information can be displayed in a form that is familiar to experts in real-time locally, or can be stored for subsequent retrieval or transmitted for remote review. | 03-08-2012 |
| 20120088997 | Implantable biochip for managing trauma--induced hemorrhage - A biocompatible biosensor and transmitter device for temporary implantation prior to, during and following trauma-induced hemorrhaging detects the presence and level of at least one analyte and transmits detected data to a second, external device. Thus, a method for managing post-trauma patient outcomes includes providing such a biosensor and transmitter device, temporarily implanting the biocompatible biosensor and transmitter device intramuscularly in a trauma victim; and monitoring the presence and level of the at least one analyte detected by the biocompatible biosensor and transmitter device and transmitted to the external data receiving means. | 04-12-2012 |
| 20120220845 | SHOCK OR SEPSIS EARLY DETECTION METHOD AND SYSTEM - According to various embodiments, a medical system and method for early detection of shock and/or sepsis may include devices configured to provide information about carbon dioxide and/or pH levels in a patient's tracheal tissue and in a respiratory path. Specifically, a relationship between carbon dioxide and/or pH in the tracheal tissue vs. respiratory gases (e.g., lung gases) may be used to determine if a patient is at risk of developing shock or sepsis. In certain embodiments, if carbon dioxide in the tracheal tissue deviates from end-tidal carbon dioxide, a patient may be experiencing early stages of hypoperfusion associated with shock and/or sepsis. | 08-30-2012 |
| 20120220846 | SYSTEM AND METHOD FOR DIAGNOSING SLEEP APNEA - Various embodiments may provide methods and systems capable of evaluating physiological parameter data. The methods and systems may include monitoring a patient to produce a signal comprising a sequence of numerical values for blood oxygen saturation over a time period. The signal may be analyzed to identify two or more desaturation patterns within the time period, and at least two numerical differences are calculated between the desaturation patterns. A saturation pattern detection index may be calculated using the numerical differences between the desaturation patterns. The saturation pattern detection index may be used to provide an indication of a physiological condition. Other embodiments may provide a medical device that may be used to evaluate physical parameter data according to the techniques described. | 08-30-2012 |
| 20120296188 | DEVICES AND METHODS FOR MEASURING OXYGEN - A sensor for measuring oxygen concentration in a tissue or an organ of a subject is provided. The sensor includes a sensory element comprising at least one paramagnetic spin probe compound encapsulated in a biocompatible oxygen permeable material. A barrier layer partially covers the sensory element and is comprised of at least one biocompatible oxygen impermeable material. Oxygen concentration data may be acquired by applying the sensor to the tissue or the organ of the subject, and subsequently applying a magnetic resonance spectroscopy or imaging technique. | 11-22-2012 |
| 20120316413 | MEASUREMENT APPARATUS - Disclosed is a measurement apparatus that includes a main body, a signal processing module disposed inside the main body, a first data communication interface coupled with the signal processing module, and a signal collection module coupled with the signal processing module; the signal collection module functions to measure the physiological parameter signal and output the physiological parameter signal to the signal processing module; the signal processing module functions to process the physiological parameter signal to generate the physiological parameter data, and output the physiological parameter data to the terminal device via the first data communication interface, such that the terminal device can display the physiological parameter data. The user can directly conduct the physiological parameter measurement using the measurement apparatus according to the present invention without any specialized measurement equipment. | 12-13-2012 |
| 20130035574 | MICROFLUIDIC DRUG DELIVERY DEVICES WITH VENTURI EFFECT - The methods, systems, and devices disclosed herein generally involve convection-enhanced delivery of drugs to a target region within a patient. Microfluidic catheter devices are disclosed that are particularly suitable for targeted delivery of drugs via convection, including devices capable of multi-directional drug delivery, devices that control fluid pressure and velocity using the venturi effect, and devices that include conformable balloons. Methods of treating various diseases using such devices are also disclosed, including methods of treating cerebral and spinal cavernous malformations, cavernomas, and hemangiomas, methods of treating neurological diseases, methods of treatment using multiple microfluidic delivery devices, methods of treating hearing disorders, methods of spinal drug delivery using microfluidic devices, and methods of delivering stem cells and therapeutics during fetal surgery. Methods of manufacturing such devices are also disclosed. | 02-07-2013 |
| 20130041241 | PECVD COATING METHODS FOR CAPPED SYRINGES, CARTRIDGES AND OTHER ARTICLES - A method is disclosed in which a vapor-deposited coating or layer is directly or indirectly applied to at least a portion of the internal wall of the barrel of a capped pre-assembly comprising a barrel, optionally a dispensing portion, and a cap. The cap is secured to the barrel and at least substantially isolates the distal opening of the dispensing portion from pressure conditions outside the cap. A vapor-deposited coating or layer is applied directly or indirectly to at least a portion of the internal wall of the barrel while the pre-assembly is capped. The coating or layer is applied under conditions effective to maintain communication from the barrel lumen to the exterior via the front opening, optionally further via the dispensing portion lumen if present, at the end of the applying step. The capped pre-assembly can be pressure tested easily and rapidly, for example with a test duration between 1 and 60 seconds, to determine whether it has container closure integrity. | 02-14-2013 |
| 20130046164 | Implantable Dissolved Oxygen Sensor and Methods of Use - A sensor is provided for measuring a dissolved oxygen concentration in vivo when implanted at a tissue site and in ex vivo applications. The sensor includes an article comprising a sensing medium retained within the implantable article by an oxygen-permeable material. The sensing medium comprises an MR contrast agent for oxygen. The sensor is configured to indicate the dissolved oxygen concentration of a fluid, e.g., in vivo at the tissue site, when subjected to an MR-based method. | 02-21-2013 |
| 20130085357 | HAEMODYNAMIC MONITORING DEVICE - A relation is formed between an n-tuple having n components and formed at a first point in time and at least one other n-tuple having n components formed at at least one corresponding later point in time, wherein n is a natural number equal to or greater than 1, and the components comprise at least one derived parameter and/or one read-in data value. If this relationship satisfies a predetermined calibration criterion, a calibration signal is triggered and is displayed, and/or automatically triggers a recalibration of the haemodynamic monitoring device. For example, the pulse contour cardiac output PCCO is derived from the arterial pressure curve as the constituent component of a 1-tuple. As long as this differs from the reference cardiac output CO | 04-04-2013 |
| 20130109941 | METHODS AND SYSTEMS FOR PHOTOACOUSTIC SIGNAL PROCESSING | 05-02-2013 |
| 20130137951 | Skin Permeation Device for Analyte Sensing or Transdermal Drug Delivery - Devices, systems, kits and methods for increasing the skin's permeability controlled by measured skin electrical parameter are described herein. They may be used for transdermal drug delivery and/or analyte extraction or measurement. The controlled abrasion device contains (i) a hand piece, (ii) an abrasive tip, (iii) a feedback control mechanism, (iv) two or more electrodes, and (v) an electrical motor. Preferably the feedback control mechanism is an internal feedback control mechanism. In this embodiment, the abrasive tip contains two electrodes, i.e. both the source electrode and the return electrode. In another embodiment, the feedback control mechanism is an external feedback control. In the preferred embodiment for external feedback control, the device contains a co-axial or concentric arrangement of the two electrodes. In this embodiment, the abrasive tip contains the source electrode and the return electrode is located at the proximal end of the hand piece. The abrasive tip can be made of any material with a surface that can abrade skin. The material can be conductive or non-conductive. The controlled abrasion device may be provided in a kit, where the kit contains the device, one or more abrasive tips, optionally with a wetting fluid. The method for increasing the skin's permeability requires applying the controlled abrasion device to a portion of the skin's surface for a short period of time. The desired level of skin impedance, and thus the resulting permeability of the treated site, can be set at a predetermined value. Alternatively, the level of skin impedance can be selected based on the desired level of skin integrity, the subject's sensation of discomfort, or the duration of the application. The device contains a control mechanism which uses an appropriate algorithm or signal processing on the conductivity information provided by the electrodes to determine when the desired level of skin permeability has been reached. Once the desired level has been reached, the abrasion device is removed and either a drug delivery composition or device or an analyte sensor is applied to the treated site. | 05-30-2013 |
| 20130190582 | ISCHEMIC REGION DETECTION - An ischemia detecting system has an implantable medical device connectable to an LV cardiac catheter with sensors for generating sensor signals representative of the concentration of a constituent in coronary venous blood at different sites in the coronary venous system. The sensor signals are co-processed by the system to detect an ischemic region of the subject's heart based on a relation between the sensor signals. The detection of the particular ischemic cardiac region is possible by conducting the concentration monitoring on either sides of a branching vein in the coronary venous system and co-processing the sensor signals. | 07-25-2013 |
| 20130303868 | DETECTION DEVICE FOR THE DETECTION OF A BLOOD COUNT PARAMETER - A detection device for detecting a blood count parameter in a blood vessel, comprising a transmitter having a number of transmit antennas for transmitting at least one transmit signal, a receiver having a number of receive antennas for receiving at least one receive signal, a processor to select a detection configuration comprising one of the transmit antennas and one of the receive antennas and select a second detection configuration comprising one of the transmit antennas and one of the receive antennas, and a loss detector that is designed, when the first detection configuration is selected to transmit a transmit signal, to detect a first loss value on the basis of the transmit signal and a receive signal, and, when the second detection configuration is selected to transmit a transmit signal, detect a second loss value on the basis of the transmit signal and a receive signal. The processor is designed to select the detection configuration having the lower loss value to detect the blood count parameter. | 11-14-2013 |
| 20130324821 | DEVICE FOR DIAGNOSING CONDITION OF LIVER AND METHOD OF EXAMINING CONDITION OF LIVER - The diagnostic device disclosed in this application is a device for diagnosing liver condition. The diagnostic device comprises a nitric oxide sensor and an information output unit. The nitric oxide sensor can be brought into contact with hepatocytes making up the liver and detects the concentration of nitric oxide produced by the hepatocytes. The information output unit, based on the nitric oxide concentration detected by the nitric oxide sensor, outputs information for diagnosing the condition of the liver. The information output unit can, for example, output a graph showing the change over time in the nitric oxide concentration detected by the nitric oxide sensor. | 12-05-2013 |
| 20130338463 | Integrated Introducer and Transmitter Assembly and Methods of Use - Method and apparatus for inserting at least a portion of a sensor into a patient is provided. | 12-19-2013 |
| 20140031656 | TRACHEAL TUBE SENSOR DISPOSED ON PERMEABLE MEMBRANE - Various embodiments of an tracheal tube having a sensor coupled to a selectively permeable membrane are provided. In some embodiments, the membrane may be permeable to one or more blood gases and/or blood analytes. Certain embodiments of the endotracheal tube may be capable of deploying the sensor during intubation to sense one or more indicators of blood flow characteristics, such as a level of blood gases and/or blood analytes, in the respiratory tract. Embodiments of the present invention may include positioning of the sensor in a variety of suitable positions with respect to the permeable membrane, such as mounting the sensor to the underside of an inflatable permeable membrane. | 01-30-2014 |
| 20140039286 | TRANSVASCULAR NERVE STIMULATION APPARATUS AND METHODS - Electrode structures for transvascular nerve stimulation combine electrodes with an electrically-insulating backing layer. The backing layer increases the electrical impedance of electrical paths through blood in a lumen of a blood vessel and consequently increases the flow of electrical current through surrounding tissues. The electrode structures may be applied to stimulate nerves such as the phrenic, vagus, trigeminal, obturator or other nerves. | 02-06-2014 |
| 20140094672 | SYSTEMS AND METHODS FOR PROCESSING PHYSIOLOGICAL SIGNALS IN WAVELET SPACE - Methods and systems are disclosed for analyzing multiple scale bands in the scalogram of a physiological signal in order to obtain information about a physiological process. An analysis may be performed to identify multiple scale bands that are likely to contain the information sought. Each scale band may be assessed to determine a band quality, and multiple bands may be combined based on the band quality. Information about a physiological process may determined based on the combined band. In an embodiment, analyzing multiple scale bands in a scalogram arising from a wavelet transformation of a photoplethysmograph signal may yield clinically relevant information about, among other things, the blood oxygen saturation of a patient. | 04-03-2014 |
| 20140235983 | System and Method for Facilitating Observation of Monitored Physiologic Data - Present embodiments are directed to a system and method capable of detecting and graphically indicating physiologic patterns in patient data. For example, present embodiments may include a monitoring system that includes a monitor capable of receiving input relating to patient physiological parameters and storing historical data related to the parameters. Additionally, the monitoring system may include a screen capable of displaying the historical data corresponding to the patient physiological parameters. Further, the monitoring system may include a pattern detection feature capable of analyzing the historical data to detect a physiologic pattern in a segment of the historical data and capable of initiating a graphical indication of the segment on the screen when the physiologic pattern is present in the segment. | 08-21-2014 |
| 20140275901 | Devices and Methods For Monitoring Oxygenation During Treatment With Delivery Of Nitric Oxide - The present invention provides devices and methods for calculating and monitoring oxygenation parameters during treatment with delivery of nitric oxide. The devices and methods of the present invention can calculate the oxygenation index based on measurements of mean airway pressure, saturation of oxygen and fraction of inspired oxygen derived from components of the present invention. Also described is a nitric oxide delivery device that incorporates a proximal pressure transducer. | 09-18-2014 |
| 20140275902 | Device Configuration for Supporting a Patient Oxygenation Test - A physiological monitor device includes a central processing unit (CPU) that is configured to control operation of the device, a display screen, and one or more computer readable data storage media storing software instructions that, when executed by the CPU, cause the device to: create or modify a patient profile, select a patient test, store one or more test parameters selected or entered for the patient test, store one or more thresholds selected or entered for at least one of the test parameters, store one or more instructions for the patient, start the test, display test results while the test is in progress, determine whether any of the test parameters exceed limits set by the one or more thresholds, take one or more actions when it is determined that one or more of the test parameters exceed the limits set by the one or more thresholds, provide a summary and analysis of the test results, and send the test results to a computing device. | 09-18-2014 |
| 20140296676 | MONITORING SYSTEM FOR CARDIAC SURGICAL OPERATIONS WITH CARDIOPULMONARY BYPASS - A monitoring system for cardiac operations with cardiopulmonary bypass comprising: a processor operatively connected to a heart-lung machine; a pump flow detecting device connected to a pump of the heart-lung machine to continuously measure the pump flow value and send it to the processor; a hematocrit reading device inserted inside the arterial or venous line of the heart-lung machine to continuously measure the blood hematocrit value and to send it to the processor; a data input device to allow the operator to manually input data regarding the arterial oxygen saturation and the arterial oxygen tension; computing means integrated in the processor to compute the oxygen delivery value on the basis of the measured pump flow, the measured hematocrit value, the preset value of arterial oxygen saturation, and the preset value of arterial oxygen tension; and a display connected to the processor to display in real-time the computed oxygen delivery value. | 10-02-2014 |
| 20150011854 | CONTINUOUS TRANSDERMAL MONITORING SYSTEM AND METHOD - Various embodiments of methods and systems for continuous transdermal monitoring (“CTM”) are disclosed. One exemplary method for CTM begins by monitoring an output signal from an accelerometer. The accelerometer output signal may indicate acceleration and deceleration of a body part of a user, such as the user's wrist. Based on the accelerometer output signal, it may be determined that the body part of the user has decelerated to a minimum, e.g., substantially zero. With a determination that the body part has decelerated to the minimum, e.g., substantially zero, or has not accelerated beyond the minimum, e.g., substantially zero, the method may determine a reading from a pulse oximeter associated with the accelerometer. Advantageously, the pulse oximetry reading, or a reading from other sensors associated with the accelerometer, may be optimally accurate as motion artifact may be minimized. The pulse oximetry reading may be recorded for later query and/or rendered for the benefit of the user. | 01-08-2015 |
| 20150099955 | REGIONAL OXIMETRY USER INTERFACE - A regional oximetry system has a display and at least one processor causing a plurality of views to be displayed on the display, each configured to occupy at least a portion of the display. The views are adapted to present data responsive to at least one physiological signal. A first sensor port is configured to receive at least a first physiological signal representative of a regional tissue oxygenation level, and a second sensor port is configured to receive at least a second physiological signal representative of an arterial oxygen saturation level. One view presents a first trend graph of the first physiological signal and a second trend graph of the second physiological signal. An area between the first trend graph and the second trend graph can include a differential analysis of regional-to-central oxygen saturation. | 04-09-2015 |
| 20150105641 | HUMAN PERFORMANCE ENHANCEMENT METHOD AND APPARATUS - A human body support, such as a chair, has a plurality of support segments that are arranged in an array. Each support segment has a protrusion elevation that is independently variable and controllable in its distance of protrusion elevation against the supported human body. A sensor is connected to a human body on the support and senses a human body parameter that can indicate the presence of drowsiness. A controller analyzes the sensed parameter to detect whether the sensed parameter is within a range indicating the presence of drowsiness. The controller applies a wave of varying segment protrusion elevation against the human body in response to the detection of drowsiness. The wave progresses in a direction from an inferior location on the human body toward a more superior location. Alternatively, a wave of electrical stimuli is applied by similarly positioned electrodes and causes periodic tightening and relaxing of proximate muscles. | 04-16-2015 |
| 20150105642 | PERFUSION SYSTEM WITH RFID FEATURE ACTIVATION - The disclosure pertains to a perfusion system that is easy to set-up, use and monitor during a bypass procedure. In some embodiments, the disclosure pertains to a perfusion system in which at least some of the disposable components used with the perfusion system are configured to be able to communicate set-up and/or operational parameters to the perfusion system in order to unlock further functionality within the perfusion system. | 04-16-2015 |
| 20150328403 | GLUCOSE CONSUMPTION MONITOR - Apparatus and methods for monitoring and indexing glucose consumption are disclosed. Embodiments of the present invention provide for accurate measurement of small differences in blood glucose values at various points in the body. These accurate measurements can be used to monitor glucose uptake in specific organs of the body such as the brain or heart. The apparatus includes an upstream intravascular glucose sensor and a downstream intravascular glucose sensor. In some embodiments, substantially simultaneous fluid communication of a calibration fluid to both glucose sensors reduces bias between the sensors. A processor is used to calculate and optionally display blood glucose consumption. Oxygen consumption can also be determined and used to determine and display an index value that is indicative of any mismatch between the two. In some embodiments, insulin and/or glucose infusion can be controlled by the system. | 11-19-2015 |
| 20160015323 | Sensor Systems - A sensor sheath for a catheter. The sensor sheath includes a substrate having at least one sensor associated therewith; and an electronics unit in communication with at the at least one sensor, wherein the substrate is configured to attach to a catheter. | 01-21-2016 |
| 20160022155 | Evaluating the Cardiac Engine - The present invention relates to computer-based methods for evaluating an individual's cardiovascular system and computer systems for use in such methods. The computer system recognizes a portion of the individual's cardiovascular system though an imaging device input, then assesses the cardiac power, energy and efficiency during the cardiac cycle. The computer system evaluates circulatory motion and properties of circulatory fluid, and further optimizes the cardiovascular analysis through suggested repositioning of the imaging device. | 01-28-2016 |
| 20160051192 | VITAL SIGNAL MEASURING WATCH AND METHOD FOR MEASURING VITAL SIGNAL - A vital signal measuring watch is provided, the vital signal measuring watch including a watch module having a shape of a wrist watch, wherein the watch module includes a device receiving portion at one side of the watch module and a communication port in the device receiving portion; and a vital signal sensor connected to or disconnected from the device receiving portion, connected to the communication port when being connected to the device receiving portion, and configured to transmit biometric data obtained by measuring vital signals to the communication port, wherein the vital signal sensor is configured to generate an interrupt plug-in event to transmit the event to the watch module when being connected to the communication port, and the watch module is configured to count a number of interrupts of the transmitted interrupt plug-in event, automatically recognize a communication protocol supported by the vital signal sensor according to the number of interrupts, and dynamically activate a communication interface to correspond to the recognized communication protocol to receive the biometric data from the vital signal sensor. | 02-25-2016 |
| 20160106379 | SP02 TONE MODULATION WITH AUDIBLE LOWER CLAMP VALUE - A patient monitor device includes one or more sensors which measure physiological parameters of a patient, a controller which controls an audio source to generate an audible tone and adjust the pitch of the audible tone to indicate the measured physiological parameter according to a mapping scheme, the audio source which generates the audio tone, and an audio output device which outputs the audible tone. The mapping scheme clamping a frequency of the audible tone after reaching a predetermined threshold. | 04-21-2016 |
| 20160159842 | COMPOUNDS, SYSTEMS, AND METHODS FOR MONITORING AND TREATING A SURFACE OF A SUBJECT - Compounds, systems, and methods are provided for the design and assembly of a non-invasive, analyte sensing dressing. The dressing can be therapeutic. The dressing includes a sensor and a matrix. The sensor is capable of detecting analytes such as molecular oxygen, carbon dioxide, nitric oxides, dissolved analytes in plasma, and hydrogen ions. The matrix is at least partially permeable to the analyte. The device emits a detectable signal when the sensor is excited in the presence of the analyte. In one version of the dressing, the sensor includes a meso-unsubstituted metallated porphyrin that is sensitive towards oxygen. The metallated porphyrin can be excited when illuminated at a first wavelength, followed by emission of phosphorescence at a second wavelength whose intensity can be used as an indicator for oxygen concentration. | 06-09-2016 |
| 20160166213 | SELF-IDENTIFYING OXIMETRY SENSOR SYSTEM | 06-16-2016 |
| 20160196649 | METHOD FOR DETERMINING AN INTRACORTICAL WORKING STATE OF A FUNCTIONAL NETWORK IN THE BRAIN | 07-07-2016 |
| 20160249838 | Method and Apparatus for Effective Detection of Respiratory Blockage Using CO2 Monitor | 09-01-2016 |
